ALSO NOTED: Cross Country expands research offering; Dyax prices shares; Sciele takes stake in Addrenex; and much more...

> Cross Country Healthcare is buying Assent Consulting for $19.6 million in a deal designed to expand its biotech research services. Release

> Dyax has priced a public offering of 10,500,00 shares of its common stock at $3.67 per share. Release

> Sciele Pharma has acquired a $6 million stake in Addrenex and simultaneously signed a marketing pact. Release

And Finally... For uninsured adults, reaching retirement age and qualifying for Medicare is an opportunity to start getting medical care. Article